- Home
- ICLR vs NMR Comparison
ICLR vs NMR Comparison
Compare ICLR & NMR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICLR
- NMR
- Stock Information
- Founded
- ICLR 1990
- NMR 1925
- Country
- ICLR Ireland
- NMR Japan
- Employees
- ICLR N/A
- NMR N/A
- Industry
- ICLR Biotechnology: Commercial Physical & Biological Resarch
- NMR Investment Bankers/Brokers/Service
- Sector
- ICLR Health Care
- NMR Finance
- Exchange
- ICLR Nasdaq
- NMR Nasdaq
- Market Cap
- ICLR 15.7B
- NMR 15.6B
- IPO Year
- ICLR 1998
- NMR 1961
- Fundamental
- Price
- ICLR $214.25
- NMR $6.04
- Analyst Decision
- ICLR Strong Buy
- NMR Hold
- Analyst Count
- ICLR 10
- NMR 1
- Target Price
- ICLR $290.60
- NMR N/A
- AVG Volume (30 Days)
- ICLR 1.9M
- NMR 790.0K
- Earning Date
- ICLR 10-23-2024
- NMR 11-01-2024
- Dividend Yield
- ICLR N/A
- NMR N/A
- EPS Growth
- ICLR 44.49
- NMR 108.50
- EPS
- ICLR 8.99
- NMR 0.62
- Revenue
- ICLR $8,306,823,000.00
- NMR $12,446,225,835.00
- Revenue This Year
- ICLR $4.00
- NMR $13.88
- Revenue Next Year
- ICLR $3.16
- NMR N/A
- P/E Ratio
- ICLR $23.84
- NMR $9.26
- Revenue Growth
- ICLR 3.63
- NMR 24.23
- 52 Week Low
- ICLR $183.38
- NMR $4.03
- 52 Week High
- ICLR $347.72
- NMR $6.62
- Technical
- Relative Strength Index (RSI)
- ICLR 41.76
- NMR 67.69
- Support Level
- ICLR $183.38
- NMR $5.94
- Resistance Level
- ICLR $217.91
- NMR $6.09
- Average True Range (ATR)
- ICLR 8.58
- NMR 0.10
- MACD
- ICLR 2.86
- NMR 0.04
- Stochastic Oscillator
- ICLR 63.64
- NMR 91.53
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.
About NMR Nomura Holdings Inc ADR
Nomura Holdings Inc is a financial services group in Japan and operates offices in countries and regions worldwide including Japan, the U.S., the U.K., Singapore, and the Hong Kong Special Administrative Region ("Hong Kong") through its subsidiaries. The company's clients include individuals, corporations, financial institutions, governments, and governmental agencies. The company's business consists of Wealth Management*, Investment Management, and Wholesale. The company generates the majority of its revenue from the wholesale segment. The Wholesale Division consists of two businesses, Global Markets, which is mainly engaged in the trading, sales, and structuring of financial products, and Investment Banking which is engaged in advisory, financing, and solutions businesses.